Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...

If your ideal winter includes a lot of snacking on nuts, you'll be happy to know that Costco has you covered - but not all ...

Achieving consistency is fraught with complexity. Go too far and you can rinse insight from Ofsted inspections ...